Attached files
| file | filename |
|---|---|
| EX-23.1 - EX-23.1 - Vir Biotechnology, Inc. | d945110dex231.htm |
| EX-10.59 - EX-10.59 - Vir Biotechnology, Inc. | d945110dex1059.htm |
| EX-10.58 - EX-10.58 - Vir Biotechnology, Inc. | d945110dex1058.htm |
| EX-10.57 - EX-10.57 - Vir Biotechnology, Inc. | d945110dex1057.htm |
| EX-10.56 - EX-10.56 - Vir Biotechnology, Inc. | d945110dex1056.htm |
| EX-10.55 - EX-10.55 - Vir Biotechnology, Inc. | d945110dex1055.htm |
| EX-10.54 - EX-10.54 - Vir Biotechnology, Inc. | d945110dex1054.htm |
| EX-10.53 - EX-10.53 - Vir Biotechnology, Inc. | d945110dex1053.htm |
| EX-10.21 - EX-10.21 - Vir Biotechnology, Inc. | d945110dex1021.htm |
| EX-5.1 - EX-5.1 - Vir Biotechnology, Inc. | d945110dex51.htm |
| EX-1.1 - EX-1.1 - Vir Biotechnology, Inc. | d945110dex11.htm |
| S-1 - S-1 - Vir Biotechnology, Inc. | d945110ds1.htm |
Exhibit 99.1
CONSENT TO BE NAMED AS A DIRECTOR NOMINEE
Vir Biotechnology, Inc., a Delaware corporation (the “Company”), is filing a Registration Statement on Form S-1 (the “Registration Statement”) with the Securities and Exchange Commission under the Securities Act of 1933, as amended (the “Securities Act”), in connection with a public offering (the “Public Offering”) of its common stock. In connection with the Public Offering, I hereby consent, pursuant to Rule 438 of the Securities Act, to being named as a nominee to the board of directors of the Company in the Registration Statement, and any amendments and supplements thereto. I also consent to the filing of this consent as an exhibit to the Registration Statement and any amendments and supplements thereto.
| /s/ Elliott Sigal |
| Name: Elliott Sigal |
| Date: July 6, 2020 |